Cargando…

Dosimetric rationale and preliminary experience in proton plus carbon-ion radiotherapy for esophageal carcinoma: a retrospective analysis

BACKGROUND: Concurrent chemoradiotherapy has been standard of care for unresectable esophageal carcinoma. There were no reports on proton radiotherapy (PRT) plus carbon-ion radiotherapy (CIRT) with pencil beam scanning (PBS) for esophageal carcinoma. This study evaluated the tolerability and efficie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Ningyi, Ming, Xue, Chen, Jian, Wu, Kai-Liang, Lu, Jiade, Jiang, Guoliang, Mao, Jingfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693034/ https://www.ncbi.nlm.nih.gov/pubmed/38041122 http://dx.doi.org/10.1186/s13014-023-02371-9

Ejemplares similares

Definitive carbon ion radiotherapy for tracheobronchial adenoid cystic carcinoma: a preliminary report
por: Chen, Jian, et al.
Publicado: (2021)

Preliminary Safety and Efficacy of Proton Plus Carbon-Ion Radiotherapy With Concurrent Chemotherapy in Limited-Stage Small Cell Lung Cancer
por: Ma, Ning-Yi, et al.
Publicado: (2021)

Adaptive carbon ion radiotherapy for locally advanced non‐small cell lung cancer: Organ‐sparing potential and target coverage
por: Jia, Shubing, et al.
Publicado: (2022)

Evaluating dosimetric constraints for carbon ion radiotherapy in the treatment of locally advanced pancreatic cancer
por: Lin, Lien-Chun, et al.
Publicado: (2020)

Feasibility of lattice radiotherapy using proton and carbon-ion pencil beam for sinonasal malignancy
por: Yang, Dong, et al.
Publicado: (2022)

Early stage non-small cell lung cancer treated with pencil beam scanning particle therapy: retrospective analysis of early results on safety and efficacy
por: Chen, Jian, et al.
Publicado: (2019)

Dosimetric impact of using a commercial metal artifact reduction tool in carbon ion therapy in patients with hip prostheses
por: Zhao, Jingfang, et al.
Publicado: (2021)

Comparison of the efficacy and toxicity of postoperative proton versus carbon ion radiotherapy for head and neck cancers
por: Huang, Qingting, et al.
Publicado: (2022)

Perfusion MR prior to radiotherapy is a strong predictor of survival in high-grade gliomas after proton and carbon ion radiotherapy
por: Qiu, Xianxin, et al.
Publicado: (2022)

The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine
por: Guan, Xiyin, et al.
Publicado: (2019)

In silico comparison of the dosimetric impacts of a greater omentum spacer for abdominal and pelvic tumors in carbon-ion, proton and photon radiotherapy
por: Yamada, Masayoshi, et al.
Publicado: (2019)

Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma
por: Abe, Takanori, et al.
Publicado: (2015)

Dosimetric analysis and biological evaluation between proton radiotherapy and photon radiotherapy for the long target of total esophageal squamous cell carcinoma
por: Cui, Yongbin, et al.
Publicado: (2022)

Flourish of Proton and Carbon Ion Radiotherapy in China
por: Li, Yue, et al.
Publicado: (2022)

Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma
por: Kong, Lin, et al.
Publicado: (2016)

METTL3‐mediated m6A mRNA contributes to the resistance of carbon‐ion radiotherapy in non‐small‐cell lung cancer
por: Xu, Xiaofeng, et al.
Publicado: (2022)

Dosimetric comparison between stereotactic body radiotherapy and carbon-ion radiation therapy for prostate cancer
por: Huang, He-Fa, et al.
Publicado: (2023)

Carbon-ion radiotherapy boost with standard dose proton radiation for incomplete-resected high-grade glioma: a phase 1 study
por: Qiu, Xianxin, et al.
Publicado: (2022)

Evaluation of Automatic Segmentation Model With Dosimetric Metrics for Radiotherapy of Esophageal Cancer
por: Zhu, Ji, et al.
Publicado: (2020)

Carbon-ion radiotherapy in the treatment of radiation-induced second primary malignancies
por: Yang, Jing, et al.
Publicado: (2022)

The role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx
por: Hu, Jiyi, et al.
Publicado: (2022)

Intensity-modulated carbon-ion radiation therapy versus intensity-modulated photon-based radiation therapy in locally recurrent nasopharyngeal carcinoma: a dosimetric comparison
por: Wang, Lei, et al.
Publicado: (2019)

Dosimetric comparison of carbon ion and X-ray radiotherapy for Stage IIIA non–small cell lung cancer
por: Kubo, Nobuteru, et al.
Publicado: (2016)

Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy
por: Oonsiri, Puntiwa, et al.
Publicado: (2022)

Clinical outcomes of carbon‐ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma
por: Hu, Jiyi, et al.
Publicado: (2020)

A Comparison Study of Machine Learning (Random Survival Forest) and Classic Statistic (Cox Proportional Hazards) for Predicting Progression in High-Grade Glioma after Proton and Carbon Ion Radiotherapy
por: Qiu, Xianxin, et al.
Publicado: (2020)

Intensity-modulated proton and carbon-ion radiation therapy in the management of major salivary gland carcinomas
por: Huang, Qingting, et al.
Publicado: (2022)

Intrafractional dose variation and beam configuration in carbon ion radiotherapy for esophageal cancer
por: Haefner, M. F., et al.
Publicado: (2016)

Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma
por: Hu, Jiyi, et al.
Publicado: (2021)

Intensity‐Modulated Proton and Carbon‐Ion Radiation Therapy in the Management of Head and Neck Sarcomas
por: Yang, Jing, et al.
Publicado: (2019)

Dosimetric characterization of whole brain radiotherapy of pediatric patients using modulated proton beams
por: Jin, Hosang, et al.
Publicado: (2011)

Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma
por: Kong, Lin, et al.
Publicado: (2016)

Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy
por: Vischioni, Barbara, et al.
Publicado: (2022)

Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial
por: Kong, Lin, et al.
Publicado: (2019)

The Majority of United States Citizens With Cancer do not Have Access to Carbon Ion Radiotherapy
por: Foote, Robert L., et al.
Publicado: (2022)

In vitro evaluation of photon and carbon ion radiotherapy in combination with cisplatin in head and neck squamous cell carcinoma cell lines
por: Fang, Xumeng, et al.
Publicado: (2023)

The Impact of Lymphopenia and Dosimetric Parameters on Overall Survival of Esophageal Cancer Patients Treated with Definitive Radiotherapy
por: Liu, Ming, et al.
Publicado: (2021)

Proton or Carbon Ion Therapy for Skull Base Chordoma: Rationale and First Analysis of a Mono-Institutional Experience
por: Tubin, Slavisa, et al.
Publicado: (2023)

Impact of Breast Size on Dosimetric Indices in Proton Versus X-ray Radiotherapy for Breast Cancer
por: Cunningham, Lisa, et al.
Publicado: (2021)

Dosimetric verification in water of a Monte Carlo treatment planning tool for proton, helium, carbon and oxygen ion beams at the Heidelberg Ion Beam Therapy Center
por: Tessonnier, T, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ce5r0obiv9r39iangsoud4fa2s